AstraZeneca PLC

STO:AZN

AstraZeneca is a global pharmaceutical company that discovers, develops, and sells prescription medicines. Its drugs treat major illnesses such as cancer, heart and kidney disease, respiratory conditions, and rare diseases. The company works with doctors, hospitals, and health systems, and it earns money mainly by selling patented medicines and, in some cases, by licensing or partnering on drug programs. What makes AstraZeneca’s business different is that it focuses on highly specialized medicines that usually require years of research, clinical testing, and regulatory approval before they can be sold. That makes the company more dependent on scientific success and patent protection than a typical consumer business. Once a drug is approved, the company benefits from selling it to healthcare providers and insurers, often through national health systems or reimbursement channels. For beginners, the key idea is that AstraZeneca sits near the center of the drug value chain: it turns scientific research into approved treatments and then markets those treatments to the healthcare system. Its business is built around a portfolio of medicines rather than one broad product line, so the company’s results depend on how well its drugs perform in real-world medical use and how long they stay protected from direct competition.